India has ordered 300 million doses of an unapproved coronavirus vaccine
INDIAN authorities ordered 300 million doses of an unapproved Covid-19 vaccine today as the nation continues to struggle with its severe outbreak.
The unnamed vaccine from Indian firm Biological E is in phase-three trials and is showing “promising results,” according to the federal government.
The 300 million doses cost approximately $206 million (£145m). The vaccine is likely to become available in the next few months, according to the government.
Similar stories
On Hiroshima Day, Campaign for Nuclear Disarmament general secretary SOPHIE BOLT explains why the danger of nuclear conflict is growing daily
The biggest strike in global history is a template for our future. The silence tells you all you need to know, writes CLAUDIA WEBBE



